Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
June 14 2023 - 4:02PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
SEC
File Number:
000-55008
NOTIFICATION
OF LATE FILING
(Check
One): |
☐
Form 10-K ☐ Form 20-F ☐ Form
11-K ☒ Form 10-Q ☐ Form 10-D
☐ Form N-SAR ☐ Form N-CSR |
For
Period Ended: April 30, 2023
| ☐ | Transition
Report on Form 10-K |
| ☐ | Transition
Report on Form 20-F |
| ☐ | Transition
Report on Form 11-K |
| ☐ | Transition
Report on Form 10-Q |
| ☐ | Transition
Report on Form N-SAR |
| For
the Transition Period Ended: ________________________ |
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
If
the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
PART
I -- REGISTRANT INFORMATION
ORGANICELL
REGENERATIVE MEDICINE, INC.
Full
Name of Registrant
____________________________
Former
Name if Applicable
3321 College Avenue, Suite 246
Address
of Principal Executive Office (Street and Number)
Davie, Florida 33314
City,
State and Zip Code
PART
II -- RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if appropriate.)
|
(a) |
The reasons
described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
|
|
|
☒ |
(b) |
The subject annual report,
semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion
thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before
the fifth calendar day following the prescribed due date; and |
|
|
|
|
(c) |
The accountant’s statement
or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART
III -- NARRATIVE
State
below in reasonable detail why the Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR or the transition report portion thereof, could not
be filed within the prescribed time period. (Attach extra sheets if needed.)
The compilation, dissemination and review of the
information required to be presented in the Quarterly Report on Form 10-Q for the quarter ended April 30, 2023 could not be completed
and filed by June 14, 2023, without undue hardship and expense to the registrant. The registrant anticipates that it will file its Quarterly
Report on Form 10-Q for the quarter ended April 30, 2023 within the applicable “grace” period provided by Securities Exchange
Act Rule 12b-25.
PART
IV -- OTHER INFORMATION
(1)
Name and telephone number of person to contact in regard to this notification
Ian
Bothwell |
|
310 |
|
200-9741 |
(Name) |
|
(Area
Code) |
|
(Telephone
Number) |
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s)
been filed? If the answer is no, identify report(s).
☒ Yes ☐ No
(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or portion thereof?
☐ Yes ☒ No
If
so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why
a reasonable estimate of the results cannot be made.
Organicell Regenerative Medicine Inc.
(Name
of Registrant as Specified in Charter)
Has
caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
Date: June 14, 2023 |
By: |
/s/ Ian Bothwell |
|
|
Ian Bothwell, |
|
|
Chief Financial Officer |
Organicell Regenerative ... (QB) (USOTC:OCEL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Organicell Regenerative ... (QB) (USOTC:OCEL)
Historical Stock Chart
From Jul 2023 to Jul 2024